Dr. Anita Tharian, DO
What this data tells you about Dr. Tharian
Dr. Anita Tharian is an internal medicine specialist in Mesquite, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tharian performed 37,980 Medicare services across 1,589 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tharian received a total of $10,217 from 88 pharmaceutical and/or device companies across 529 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tharian is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 24,480 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 5,041 | $18 | $64 |
| Dexamethasone injection (steroid) | 2,652 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 2,201 | $0 | $1 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 845 | $475 | $1,376 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 479 | $23 | $105 |
| Administration of chemotherapy into vein, 1 hour or less | 276 | $102 | $430 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 203 | $1,233 | $6,313 |
| 3D screening mammography (tomosynthesis) | 167 | $51 | $200 |
| Screening mammography | 166 | $125 | $488 |
| Drug injection, under skin or into muscle | 166 | $10 | $44 |
| Office visit, established patient (20-29 min) | 144 | $66 | $280 |
| Office visit, established patient (10-19 min) | 137 | $40 | $205 |
| Injection, diphenhydramine hcl, up to 50 mg | 130 | $1 | $2 |
| Office visit, established patient (30-39 min) | 120 | $100 | $291 |
| Administration of additional new drug or substance into vein, 1 hour or less | 105 | $52 | $208 |
| Office visit, established patient, complex (40-54 min) | 104 | $140 | $427 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 99 | $99 | $433 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 74 | $47 | $223 |
| Unclassified drugs | 72 | $4 | $7 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 57 | $34 | $200 |
| Bone density scan (DEXA) | 43 | $31 | $101 |
| New patient office visit (45-59 min) | 40 | $125 | $437 |
| Diagnostic mammography of 1 breast | 34 | $72 | $476 |
| Nuclear medicine study whole body with ct scan | 29 | $1,231 | $6,502 |
| Limited ultrasound scan of 1 breast | 28 | $64 | $303 |
| Administration of chemotherapy into vein, each additional hour | 28 | $23 | $80 |
| Diagnostic mammography of both breasts | 23 | $70 | $603 |
| New patient office visit (30-44 min) | 21 | $80 | $406 |
| Complete ultrasound scan of 1 breast | 16 | $81 | $316 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in TX.
Geographic Context
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tharian is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 9% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tharian experienced with iron infusion (feraheme)?
Does Dr. Tharian receive payments from pharmaceutical companies?
How do Dr. Tharian's costs compare to other internal medicine physicians in Mesquite?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology